Private equity would face new restrictions for deals in the health-care industry in California under legislation that a key committee advanced on Thursday.
The bill and another successful measure that would place new curbs on pharmacy benefit managers would bring some of the health-care sector’s most contested business practices under additional state government scrutiny.
The two measures were part of the more than 800 bills that the Assembly and Senate Appropriations committees considered on Thursday, the last hurdle before floor votes in both chambers ahead of the legislative session’s end on Aug. 31. The votes came just two months after …